Walleye Capital’s Select Medical SEM Stock Holding History

Walleye Capital’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-51,080	Closed	-$656K	–	5066
2025 Q3	$656K	Buy	+51,080	New	+$681K	﹤0.01%	2401
2022 Q3	–	Sell	-35,503	Closed	-$452K	–	3505
2022 Q2	$452K	Buy	+35,503	New	+$456K	0.01%	1092
2020 Q1	–	Sell	-16,890	Closed	-$212K	–	1552
2019 Q4	$212K	Buy	+16,890	New	+$182K	0.01%	1080

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Walleye Capital's SEM Position: Q4 2025 in Review

Walleye Capital sold out of Select Medical (SEM) in Q4 2025, closing a stake of 51,080 shares — an estimated $656K sold.

Walleye Capital first reported a position in SEM in Q4 2019 and held it in 3 quarters. The position peaked at $656K in Q3 2025. 268 funds tracked by Wall St. Rank hold SEM as of Q4 2025.

Walleye Capital reported no remaining Select Medical position as of Q4 2025 after selling out during the quarter.
Walleye Capital sold 51,080 Select Medical shares in Q4 2025, an estimated $656K.
Walleye Capital first reported a position in Select Medical in Q4 2019 and held it in 3 quarters.
Walleye Capital's Select Medical position peaked at $656K in Q3 2025.
268 funds tracked by Wall St. Rank held Select Medical as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.